Cybin CEO Doug Drysdale discusses learnings from psychedelic drug clinical trial missteps, provides examples of the benefits ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... in March 2019 and is administered as a nasal spray twice a week for four weeks.

Winter is a time when many people look forward to spending more time with family and friends, so it is important we reduce ...

A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...

FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...

The Federal Government is funding a national Take Home Naloxone (THN) program that makes the life-saving medication available ...

Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by inhibiting the ...

Semax, a synthetic analogue of the adrenocorticotropic hormone (ACTH), has been extensively researched for its neuroprotective and neuroregenerative properties. Developed in the late 1980s by Russian ...

A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...